8-K: Conduent to Sell Casualty Claims Solutions Business for $240 Million, Prepays $164 Million in Debt

Conduent has agreed to sell its Casualty Claims Solutions business to MedRisk for $240 million in cash and will prepay $164 million of its outstanding debt.

Summary

• Conduent Incorporated has announced the sale of its Casualty Claims Solutions business to MedRisk for $240 million in cash, subject to customary adjustments.
• The sale includes Conduent's workers compensation and auto casualty bill review solutions, services, and Strataware bill review software products.
• In 2023, the business processed approximately 29 million medical bills with around 100 clients.
• The purchase price represents approximately 9.5 times the adjusted EBITDA of the disposed business.
• The transaction is expected to close in the third quarter of 2024, pending regulatory approval and customary closing conditions.
• Conduent will also prepay $164 million of its Senior Secured Term Loan B.
• Current Conduent employees in the Casualty Claims Solutions business will join MedRisk, while Conduent will continue to provide mailroom services for current casualty claims clients, including MedRisk.

Sentiment

Score: 7

Explanation: The document conveys a positive sentiment due to the strategic divestiture and debt reduction, but there are risks associated with the transaction that temper the overall outlook.

Positives

• The sale of the Casualty Claims Solutions business will provide Conduent with $240 million in cash.
• The prepayment of $164 million in debt will reduce Conduent's financial obligations.
• The transaction aligns with Conduent's strategy to streamline its portfolio and focus on core capabilities.
• The sale multiple of 9.5 times adjusted EBITDA suggests a favorable valuation for the divested business.
• The transition of employees to MedRisk is expected to be seamless.

Negatives

• The sale of the Casualty Claims Solutions business will result in the loss of revenue and earnings from that segment.
• The transaction is subject to regulatory approvals and customary closing conditions, which could delay or prevent the sale.
• There are potential risks associated with the transition of employees and clients to MedRisk.
• The company will incur transaction costs related to the sale.

Risks

• The sale of the Casualty Claims Solutions business may not close if regulatory approvals are not obtained or closing conditions are not met.
• There are risks of unexpected costs, liabilities, or delays associated with the transaction.
• The transaction could negatively impact Conduent's stock price or operating results.
• There is a risk of litigation or regulatory actions related to the transaction.
• Conduent may face challenges in retaining and hiring key personnel during the transition.
• Contractual restrictions during the transaction period could limit Conduent's ability to pursue other business opportunities.

Future Outlook

The company expects the sale of the Casualty Claims Solutions business to close in the third quarter of 2024, subject to regulatory approvals and customary closing conditions. Conduent aims to streamline its portfolio and focus on core capabilities to fuel growth.

Management Comments

• Cliff Skelton, Conduent President and CEO, stated that the transaction is an example of the progress made in streamlining the portfolio while increasing focus on core capabilities.
• He also expressed confidence in a seamless transition for associates and clients to MedRisk.

Industry Context

The sale of the Casualty Claims Solutions business reflects a trend of companies focusing on core competencies and divesting non-core assets. MedRisk, as the nation's largest managed care organization dedicated to the physical rehabilitation of workers compensation patients, is a strategic buyer in this sector.

Comparison to Industry Standards

• The sale multiple of 9.5 times adjusted EBITDA is within the range of similar transactions in the business services and healthcare technology sectors.
• Comparable companies in the business process outsourcing space have also been divesting non-core assets to improve focus and profitability.
• The debt prepayment is a positive step towards improving Conduent's financial health, similar to other companies in the sector that are deleveraging their balance sheets.

Stakeholder Impact

• Shareholders will likely view the divestiture and debt reduction positively.
• Employees of the Casualty Claims Solutions business will transition to MedRisk.
• Clients of the Casualty Claims Solutions business will transition to MedRisk, with Conduent continuing to provide mailroom services.
• Creditors will benefit from the prepayment of debt.

Next Steps

• Conduent will seek regulatory approvals for the sale of the Casualty Claims Solutions business.
• The company will work towards satisfying the customary closing conditions for the transaction.
• Conduent will continue to provide mailroom services for current casualty claims clients, including MedRisk.
• Conduent will focus on its core capabilities following the divestiture.

Key Dates

Keywords

Conduent, MedRisk, Casualty Claims Solutions, Divestiture, Debt Prepayment, Workers Compensation, Bill Review, EBITDA, Transaction, Regulatory Approval